Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

9.5%

2 terminated/withdrawn out of 21 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

9 recruiting1 with results

Enrollment Performance

Analytics

N/A
15(75.0%)
Phase 1
4(20.0%)
Phase 3
1(5.0%)
20Total
N/A(15)
Phase 1(4)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (21)

Showing 20 of 21 trials
NCT07343986Phase 1Recruiting

Study of Low-Intensity Focused Ultrasound in Combination With Immunotherapy in Newly Diagnosed Unmethylated Glioblastoma

Role: collaborator

NCT06259708Not ApplicableCompleted

Using Low Intensity Focused Ultrasound to Modulate Deep Brain Areas for Tremor Control in Parkinson's Disease Patients.

Role: collaborator

NCT06628180Not ApplicableEnrolling By Invitation

LIFU for Chronic Pain

Role: collaborator

NCT06610877Not ApplicableRecruiting

Ultrasound Neuromodulation in Essential Tremor

Role: collaborator

NCT06367608Not ApplicableRecruiting

MRgFUS Pallidotomy for the Treatment of Task Specific Focal Hand Dystonia (TSFD)

Role: collaborator

NCT07405645Not ApplicableRecruiting

Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy

Role: collaborator

NCT05762419Phase 1Recruiting

FUS Etoposide for DMG

Role: collaborator

NCT04579692Not ApplicableActive Not Recruiting

MR Guided Focused Ultrasound (FUS) for the Treatment of Trigeminal Neuralgia

Role: collaborator

NCT03739905Not ApplicableCompleted

ExAblate Blood-Brain Barrier Opening for Treatment of Alzheimer's Disease

Role: collaborator

NCT07193953Phase 1Recruiting

Intravenous Immunoglobulin (IVIG) and Blood-Brain Barrier Disruption in Amyotrophic Lateral Sclerosis (ALS)

Role: collaborator

NCT03417297Not ApplicableActive Not Recruiting

A Pilot Study: Focused Ultrasound Thalamotomy for the Prevention of Secondary Generalization in Focal Onset Epilepsy

Role: collaborator

NCT04123535Not ApplicableRecruiting

Focused Ultrasound to Promote Immune Responses for Undifferentiated Pleomorphic Sarcoma

Role: collaborator

NCT04804709Phase 1Terminated

Non-Invasive Focused Ultrasound (FUS) With Oral Panobinostat in Children With Progressive Diffuse Midline Glioma (DMG)

Role: collaborator

NCT06053255Not ApplicableRecruiting

Use of the Neurolyser XR for the Treatment of Low Back Pain Related to Sacroiliitis

Role: collaborator

NCT02923011Phase 3Recruiting

Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

Role: collaborator

NCT03724435Terminated

Focused Ultrasound for the Treatment of Pancreatic Cancer - an International Registry

Role: lead

NCT03218475Not ApplicableSuspended

MRG FU With Radiotherapy for Palliation of H&N Cancer

Role: collaborator

NCT05262452Not ApplicableUnknown

Concurrent FOLFIRINOX Plus High Intensity Focused Ultrasound for Pancreatic Cancer

Role: collaborator

NCT03111277Not ApplicableCompleted

MR Guided Focused Ultrasound for Treatment of Neuropathic Pain

Role: collaborator

NCT03560622Not ApplicableActive Not Recruiting

Functional Neuroimaging Feedback for Focused Ultrasound Thalamotomy

Role: collaborator